| pembrolizumab based treatment |
| pembrolizumab and pemetrexed plus platin | pembrolizumab plus SoC |
non squamous cell - mNSCLC - L1 | | |
non squamous - mNSCLC - L1 - all population 3 | | |
non squamous - mNSCLC - L1 - PDL1 positive | | |
non squamous - mNSCLC - L1 - Wild Type (WT) 6 | | |